ZephyRNA Overview
- Year Founded
-
2026
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
ZephyRNA General Information
Description
Developer of siRNA inhalation drugs designed for the treatment of severe lung diseases. The company is currently operating in Stealth mode.
Contact Information
Website
www.zephyrna.comCorporate Office
- Lower Saxony
- Hanover
- Germany
Corporate Office
- Lower Saxony
- Hanover
- Germany
ZephyRNA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 12-Aug-2026 | Completed | Startup |
ZephyRNA Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ZephyRNA Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascenion | Accelerator/Incubator | |||
| Fraunhofer Venture | Venture Capital | Minority |
ZephyRNA FAQs
-
When was ZephyRNA founded?
ZephyRNA was founded in 2026.
-
Where is ZephyRNA headquartered?
ZephyRNA is headquartered in Hanover, Germany.
-
What industry is ZephyRNA in?
ZephyRNA’s primary industry is Drug Discovery.
-
Is ZephyRNA a private or public company?
ZephyRNA is a Private company.
-
What is ZephyRNA’s current revenue?
The current revenue for ZephyRNA is .
-
Who are ZephyRNA’s investors?
Ascenion and Fraunhofer Venture have invested in ZephyRNA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
